Decreased alpha-fetoprotein levels in HCV cirrhotic patients after direct-acting antiviral agents therapy. Does this indicate a reduced risk of hepatocellular carcinoma?. Issue 1 (16th February 2017) - De Leonardis, F.; Masetti, C.; Rossi, P.; Di Paolo, D.; Bosa, A.; Milana, M.; Santopaolo, F.; Cucchiarelli, S.; Pecchioli, A.; Francioso, S.; Lenci, I.; Brega, A.; et al.